OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CADL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Candel Therapeutics (CADL) Earnings Date & Reports

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CADL is expected to report earnings to fall 220.54% to -15 cents per share on September 03

Candel Therapeutics CADL Stock Earnings Reports

Q2'25

Est.

$-0.16

Q1'25

Beat

by $0.50

Q4'24

Missed

by $0.10

Q4'23

Missed

by $0.20

Q3'23

Missed

by $0.10

The last earnings report on May 13 showed earnings per share of 12 cents, beating the estimate of -37 cents. With 173.00K shares outstanding, the current market capitalization sits at 301.62M.

View a ticker or compare two or three

Compare

CADL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CADL
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CADL showed earnings on May 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

117 Kendrick Street

Phone

+1 617 916-5445

Employees

Web

https://www.candeltx.com